ENTITY
JD Health International

JD Health International (6618 HK)

433
Analysis
Consumer Staples • China
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
•23 Feb 2021 00:00•Exchange-sponsored

New DLCs and Warrants tracking the Hang Seng TECH Index

Investors can now gain exposure to Hang Seng TECH Index (HS TECH) via new SGX-listed DLCs and Warrants. DLCs and Warrants are leverage...

Share
•22 Feb 2021 10:00

Ping An Good Doctor (1833.HK) - It Is the Time to Look at Some Concerns

This article analyzed some concerns of Ping An Good Doctor in terms of its business and financials (revenue growth, net loss, online pharmacy,...

Logo
454 Views
Share
bearish•JD.com
•17 Feb 2021 16:44

JD.Com: Logistics Ops Spin-Off

Since JDH's listing, the stub has increased ~US$18.5bn., equivalent to ~12% of the market cap. The consensus target price is up around 8%. I would...

Logo
466 Views
Share
bullish•Kuaishou Technology
•09 Feb 2021 07:49

HSI Market Consultation - Name Changes as We Await the Conclusions

The conclusions of the HSI market consultation could be announced on 26 Feb along with the March review. Given recent large listings and price...

Logo
721 Views
Share
bullish•Kuaishou Technology
•04 Feb 2021 17:27

Kuaishou IPO: Trading Debut

Kuaishou priced its IPO at HK$115 and the grey market price last stood at HK$278. Our DCF sensitivity analysis shows that the grey market price is...

Logo
556 Views
Share
x